tag alzheimers-disease 
World of DTC Marketing
JUNE 1, 2021
SUMMARY: The FDA is coming under intense pressure to approve Biogen’s Alzheimer’s drug, but Aaron S. Kesselheim, a professor of medicine at Harvard Medical School via the Washington Post , says “the worst thing for people with Alzheimer’s would be to put out a product that doesn’t work.”
World of DTC Marketing
JUNE 23, 2021
Not to mention the $56,000 annual price tag. So far, no method of breaking down/removing amyloid plaques has been shown to prevent symptomatic Alzheimer’s disease in humans. Aduhelm joins a group of drugs that potentially leave patients worse off and much poorer for it. Why didn’t they listen to their advisory panel?
Expert insights. Personalized for you.
187 
Let's personalize your content